ProfileGDS4459 / ENSG00000117682
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 53% 29% 75% 54% 63% 41% 76% 73% 73% 75% 50% 71% 73% 42% 69% 48% 14% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.5153
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.7629
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.875
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.6254
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.9263
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.0641
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.8776
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.6273
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.6673
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.7375
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.2850
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.4971
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.5773
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.1642
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.3269
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.3248
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.1114